Thyme Care raises $125 million, pushing cancer care startup's valuation above $2 billion
CNBC · C · trust 52/100
Thyme Care has raised $125 million from investors in a deal doubling the cancer startup's valuation as it tackles critical disease treatment gaps.
Read the original at CNBC →
Open in TruthVane →